Search
for
Sort by
Research 31–60 of 1000+
- Persistent Alopecia in a Breast Cancer Patient Following Taxane Chemotherapy and Adjuvant Endocrine Therapy: Case Report and Review of Post-treatment Hair Loss in Oncology Patients with Breast Cancer
- The Potential of Ultrasound Technology and Chemotherapy Carriers in Breast Cancer Treatment
- Supplementary Material for: Patient Preferences: Results of a German Adaptive Choice-Based Conjoint Analysis (Market Research Study Sponsored by Eli Lilly and Company) in Patients on Palliative Treatment for Advanced Breast Cancer
- A prospective exploration of symptom burden clusters in women with breast cancer during chemotherapy treatment
- Anlotinib or Bevacizumab Combined with Taxane/Capecitabine for the Second-Line or Subsequent Treatment of HER-2 Negative Metastatic Breast Cancer: A Retrospective Cohort Study
- A plain language summary of quality of life with sacituzumab govitecan treatment in the TROPiCS-02 study in participants with breast cancer (HR-positive/HER2-negative)
- Supplementary Material for: Patient Preferences: Results of a German Adaptive Choice-Based Conjoint Analysis (Market Research Study Sponsored by Eli Lilly and Company) in Patients on Palliative Treatment for Advanced Breast Cancer
- 51895 Interim Analysis of Platelet-Rich Plasma (PRP) Treatment for Endocrine Therapy-Induced Alopecia (EIA) and Permanent Chemotherapy-Induced Alopecia (pCIA) in Breast Cancer Patients: A Randomized Controlled Trial
- Hormone receptor positive, HER2 negative metastatic breast cancer: Impact of CDK4/6 inhibitors on the current treatment paradigm
- 0478 Outcomes of oral dutasteride and oral minoxidil for treating endocrine therapy-induced alopecia from breast cancer treatment: A case series
- The Use of Oral Dutasteride, Minoxidil, and Finasteride for Treating Endocrine Therapy-Induced Hair Loss from Breast Cancer Treatment: A Case Series Study
- Multicentric parallel phase II trial of the polo-like kinase 1 inhibitor BI 2536 in patients with advanced head and neck cancer, breast cancer, ovarian cancer, soft tissue sarcoma and melanoma. The first protocol of the European Organization for Research and Treatment of Cancer (EORTC) Network Of Core Institutes (NOCI)
- Racial and Ethnic Disparities in Persistent Chemotherapy-Induced Alopecia Among Women With Breast Cancer
- Autoimmune/Inflammatory Syndrome Induced by Adjuvants (ASIA) in a 56-Year-Old Patient With Silicone Breast Implants: A Case Report
- Ceramide binding to African–American hair fibre correlates with resistance to hair breakage
- Curly hair: measured differences and contributions to breakage
- Alternative protocol for hair damage assessment and comparison of hair care treatments
- Finasteride Treatment of Hair Loss in Women
- Prevention of chemically induced hair damage by means of treatment based on proteins and polysaccharides
- Testosterone Treatment in Women – An Overview
- Synthetic hair reactions and treatment of complications: Case reports
- Clinical aspect, pathogenesis and therapy options of alopecia induced by hormonal therapy for breast cancer
- A Nourishing Botanical Treatment for Stronger Roots, Fuller Lengths, and Long-Term Hair Restoration
- A Nourishing Botanical Treatment for Stronger Roots, Fuller Lengths, and Long-Term Hair Restoration
- Breaking the biofilm- A persistent case of deep pyoderma in a Bullykutta dog
- Ductal breast cancer in a male patient
- Transient mitochondrial DNA double strand breaks in mice cause accelerated aging phenotypes in a ROS-dependent but p53/p21-independent manner
- Safety of testosterone treatment in postmenopausal women
- Mechanical characterization of curly hair: Influence of the use of nonconventional hair straightening treatments
- American Society for Laser Medicine and Surgery 2019 Late Breaking Abstracts